CA Patent

CA2651159A1 — Pharmaceutical compositions and uses thereof

Assigned to Activbiotics Pharma LLC · Expires 2007-10-18 · 19y expired

What this patent protects

The invention features pharmaceutical compositions including rifalazil, a surfactant, and a lipophilic antioxidant and methods of use thereof.

USPTO Abstract

The invention features pharmaceutical compositions including rifalazil, a surfactant, and a lipophilic antioxidant and methods of use thereof.

Drugs covered by this patent

octreotide-acetate (OCTREOTIDE ACETATE)

Patent Metadata

Patent number: CA2651159A1
Jurisdiction: CA
Classification: —
Expires: 2007-10-18
Drug substance claim: No
Drug product claim: No
Assignee: Activbiotics Pharma LLC
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.